"VSports手机版" Xanthohumol inhibits non-small cell lung cancer via directly targeting T-lymphokine-activated killer cell-originated protein kinase
- PMID: 36882184
- DOI: 10.1002/ptr.7799
"VSports app下载" Xanthohumol inhibits non-small cell lung cancer via directly targeting T-lymphokine-activated killer cell-originated protein kinase
Abstract
Xanthohumol is a principal prenylated chalcone isolated from hops. Previous studies have shown that xanthohumol was effective against various types of cancer, but the mechanisms, especially the direct targets for xanthohumol to exert an anticancer effect, remain elusive. Overexpression of T-lymphokine-activated killer cell-originated protein kinase (TOPK) promotes tumorigenesis, invasion and metastasis, implying the likely potential for targeting TOPK in cancer prevention and treatment. In the present study, we found that xanthohumol significantly inhibited the cell proliferation, migration and invasion of non-small cell lung cancer (NSCLC) in vitro and suppressed tumor growth in vivo, which is well correlated with inactivating TOPK, evidenced by reduced phosphorylation of TOPK and its downstream signaling histone H3 and Akt, and decreased its kinase activity VSports手机版. Moreover, molecular docking and biomolecular interaction analysis showed that xanthohumol was able to directly bind to the TOPK protein, suggesting that TOPK inactivation by xanthohumol is attributed to its ability to directly interact with TOPK. The findings of the present study identified TOPK as a direct target for xanthohumol to exert its anticancer activity, revealing novel insight into the mechanisms underlying the anticancer activity of xanthohumol. .
Keywords: TOPK; direct target; non-small cell lung cancer; xanthohumol. V体育安卓版.
© 2023 John Wiley & Sons Ltd.
References
REFERENCES
-
- Abe, Y., Matsumoto, S., Kito, K., & Ueda, N. (2000). Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells. The Journal of Biological Chemistry, 275(28), 21525-21531. https://doi.org/10.1074/jbc.M909629199
-
- Ayllon, V., & O'Connor, R. (2007). PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response. Oncogene, 26(24), 3451-3461. https://doi.org/10.1038/sj.onc.1210142
-
- Benelli, R., Vene, R., Ciarlo, M., Carlone, S., Barbieri, O., & Ferrari, N. (2012). The AKT/NF-kappaB inhibitor xanthohumol is a potent anti-lymphocytic leukemia drug overcoming chemoresistance and cell infiltration. Biochemical Pharmacology, 83(12), 1634-1642. https://doi.org/10.1016/j.bcp.2012.03.006 (V体育平台登录)
-
- Chen, Q. H., Fu, M. L., Chen, M. M., Liu, J., Liu, X. J., He, G. Q., & Pu, S. C. (2012). Preparative isolation and purification of xanthohumol from hops (Humulus lupulus L.) by high-speed counter-current chromatography. Food Chemistry, 132(1), 619-623. https://doi.org/10.1016/j.foodchem.2011.10.098
-
- Diao, X., Yang, D., Chen, Y., & Liu, W. (2019). Baicalin suppresses lung cancer growth by targeting PDZ-binding kinase/T-LAK cell-originated protein kinase. Bioscience Reports, 39(4), BSR20181692. https://doi.org/10.1042/BSR20181692 (VSports注册入口)
MeSH terms
- V体育官网 - Actions
- Actions (VSports手机版)
- Actions (V体育ios版)
Substances
Grants and funding
VSports在线直播 - LinkOut - more resources
V体育安卓版 - Full Text Sources
"V体育2025版" Medical